The year's new drugs.
Twenty-three new biological drugs and diagnostic agents reached their first markets in 2004. The oncolytic drugs therapeutic group was the most active in terms of new launches, with seven market introductions, and the United States was the most active single market for new products, with a total of 10 new launches in 2004.